DIVIS LABORATORIES
Back to All Ratios
|
DIVIS LABORATORIES Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| ROCE(%) | 20.45 | 16.46 | 19.36 | 35.06 | 32.07 |
What is the latest Return on Capital Employed (ROCE) ratio of DIVIS LABORATORIES ?
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2025 | 20.45 |
| Mar2024 | 16.46 |
| Mar2023 | 19.36 |
| Mar2022 | 35.06 |
| Mar2021 | 32.07 |
How is Return on Capital Employed (ROCE) of DIVIS LABORATORIES Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2025 | 20.45 | 24.24 | |
| Mar2024 | 16.46 | -14.98 | |
| Mar2023 | 19.36 | -44.78 | |
| Mar2022 | 35.06 | 9.32 | |
| Mar2021 | 32.07 | - | |
Other Financial Ratios of DIVIS LABORATORIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹159,375.7 Cr | -5.6% | -7.3% | 1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,905.0 Cr | -5.2% | -7.6% | -8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,788.0 Cr | -0.6% | 4.8% | 25% | Stock Analytics | |
| CIPLA | ₹110,628.0 Cr | -4.5% | -9.7% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,441.5 Cr | -2.6% | -9.7% | -10.5% | Stock Analytics | |
| MANKIND PHARMA | ₹86,682.9 Cr | -6.4% | -3.4% | -16.6% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -5.6% |
-7.3% |
1.5% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses